CELG—Discussion of positive Abraxane trial in pancreatic cancer, with musings on the (somewhat questionable) economics: http://www.nytimes.com/2013/01/23/business/pancreatic-cancer-drug-found-to-extend-life.html p.s. PGS predicted the exact HR=0.72 on Twitter before the results were announced today.